Have a question?
Please get in touch with our team in case of any queries
THE BONE GROWTH PRODUCT MARKET SIZE WAS VALUED AT USD 1.1 BILLION IN 2021 AND IS EXPECTED TO REACH USD 1.4 BILLION BY 2027, GROWING AT A CAGR OF 3.60% DURING THE PERIOD 2022-2027.
The Bone Growth Product Market Size, Share, & Trends Analysis Report by
- Product Type: Bone Growth Stimulator Device, Bone Morphogenic Protein, Platelet Rich Plasma
- Application: Spinal Fusion Surgeries, Oral and Maxillofacial Surgeries, Delayed Union and Non-Union Bone Fracture, and Others
- End-User: Hospitals and Clinic, Specialty Orthopaedic and Spine Center, and Ambulatory Surgery Centers
- Geography: Europe, North America, APAC, Latin America, and the Middle East and Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2022–2027.
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
BONE GROWTH PRODUCT MARKET REPORT SCOPE
REPORT ATTRIBUTE | DETAILS |
---|---|
MARKET SIZE | USD 1.4 Billion (2027) |
CAGR | 3.60% (2022-2027) |
BASE YEAR | 2021 |
FORECAST PERIOD | 2022–2027 |
MARKET SEGMENTS | Product Type (Bone Growth Stimulator Device, Bone Morphogenic Protein, Platelet Rich Plasma), Application (Spinal Fusion Surgeries, Oral and Maxillofacial Surgeries, Delayed Union and Non-Union Bone Fracture, and Others), End-User (Hospitals and Clinic, Specialty Orthopaedic and Spine Center, and Ambulatory Surgery Centers) |
GEOGRAPHICAL ANALYSIS | Europe, North America, APAC, Latin America, and Middle East and Africa |
COUNTRIES COVERED | US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, South Africa |
MARKET INSIGHTS
The global bone growth product market is expected to grow at a CAGR of 3.60% from 2022 to 2027, and it is projected to reach USD 1.4 billion in 2027 from USD 1.1 billion. Bone growth stimulator devices, bone morphogenetic proteins, and platelet-rich plasma help repair bone damage and speed up the bone healing process. Bone regeneration comprises a well-orchestrated series of biological events of bone induction and conduction involving several cell types and intracellular and extracellular molecular-signaling pathways, with a definable temporal and spatial sequence to optimize skeletal repair and restore skeletal functions. The global bone growth products are vast and offer significant opportunities for new vendors if they develop and commercialize breakthrough bone growth products. As a result, many local and emerging players are actively developing innovative bone stimulators for treating various bone disorders. However, as key players account for dominant shares and have superior product development and industrial expertise, technological advancements like self-powered implantable bone growth, non-invasive growth stimulator, and product launches are mainly driving the demand for the product.
KEY POINTS
- APAC will likely grow faster and record the highest absolute growth (33.44%) during the forecast period. In contrast, North America, which dominates the global bone growth products, will witness absolute growth (19.97%) during the forecast period.
- Vendors are actively launching innovative bone growth products to expand their customer base and increase their share in the highly competitive market. Vendors strategically focus on developing and commercial launching bone growth products to treat a broad range of bone pathology.
- The major advantage of the self-powered bone growth stimulator is that it provides an immediate solution; due to the increased benefits of the implantable bone growth stimulator device, the adoption of this type of device will be seen mainly among developed countries. Slowly multiple researchers are evaluating the efficiency and effectiveness of the product for better adoption of the business presence.
- The increasing number of cases of spinal fractures is expected to expand the business over the forecast period. The gradual shift and increasing demand for non-invasive surgery, the rapid introduction of biologics into spinal fusion, and the significant increase in cervical and lumbar disc replacements will further boost the bone growth products market during the forecast period.
SEGMENTATION ANALYSIS
- In 2021, the bone growth stimulator devices segment accounted for 51.12% of the global bone growth products market share; the ultrasonic bone growth stimulator is premarket approved (PMA) by the U.S. Food and Drug Administration (FDA) as a Class III Device, thereby, various changes have been incorporated into the device and given additional approval. This device is now known as the Exogen device (i.e., 2000, 3000, 4000).
- The spinal fusion surgeries segment dominates the global bone growth products market, accounting for a share of 58.24%, followed by oral & maxillofacial surgeries, delayed union & non-union bone fractures, and others with 18.90%, 9.78%, and 13.08%, respectively.
- In developing countries like India, the importance of MI spine surgery is also growing. The exponential growth of spinal training facilities and efficiency in private and corporate hospitals in emerging markets also contributes to the growth of the hospitals' segment in the global bone growth products.
VENDOR ANALYSIS
- Bioventus medical device company focused on developing and commercializing clinically differentiated, cost-effective, minimally invasive therapies that enhance the body's natural healing process. Its non-invasive medical devices and biological products play an essential role in supporting the body's natural healing mechanisms for treating or eliminating the pain caused by orthopedic diseases and problems, eventually aiding the product's growth.
- Colfax’s DJO is one of the world's largest suppliers of high-quality orthopedic devices, and in the U.S., Colfax acquired DJO in the first quarter of 2019. The company's products are sold in portfolios of Aircast, Chattanooga, CMF, Compex, DJO Surgical, DonJoy and Dr. Comfort, Exo, MotionMD, and ProCare.
- Medtronic develops, manufactures, and markets bone growth products and offers biologic solutions for the orthopedic and dental markets and products for the neurosurgery business. The company focuses on technological innovations and acquisitions to retain its market dominance and enhance its global bone growth products markets.
GEOGRAPHICAL ANALYSIS
- North America accounted for a share of over 41% of the global bone growth products market in 2021, due to the presence of a large pool of patient population with various spinal disorders requiring spinal fusion surgeries, higher acceptance of advanced and innovative bone growth products, and high awareness regarding the benefits of non-invasive surgery procedures are collectively supporting the market growth of bone growth products in North America.
- Europe accounted for a 27.45% share of the global bone growth products market in 2021. The major revenue contributors in Europe are Germany, the UK, France, Italy, and Spain. The growing technological advancements in design and material usage in bone growth products technology and new product approvals/ launches will also positively impact the growth during the forecast period.
- APAC offers vendors lucrative opportunities to uptake a diverse range of bone growth stimulator devices. Furthermore, favorable government initiatives, improvement in healthcare infrastructure, and increased healthcare spending are also expected to drive the bone growth products market in the region during the forecast period.
The research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
Segmentation by Product Type
- Bone Growth Stimulator Device
- Bone Morphogenic Protein
- Platelet Rich Plasma
Segmentation by Application
- Spinal Fusion Surgeries
- Oral and Maxillofacial Surgeries
- Delayed Union and Non-Union Bone Fracture
- Others
Segmentation by Application
- Hospitals and Clinic
- Specialty Orthopaedic and Spine Center
- Ambulatory Surgery Centers
Segmentation by Geography
- North America
- US
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- UK
- APAC
- China
- Japan
- India
- Australia
- South Korea
- Latin America
- Mexico
- Brazil
- Argentina
- The Middle East and Africa
- South Africa
- Saudi Arabia
- Turkey
Frequently Asked Questions
What is the size of the bone growth products and the growth rate during the forecast period?
Which region has the highest growth rate in the bone growth products market?
Who are the key players in the bone growth products industry?
What are the factors driving the demand for the bone growth products market?
What are the trends in the bone growth products market?
The bone-growing products market by revenue is expected to grow at a CAGR of over 3.60% during the period 2022–2027.
The following factors are likely to contribute to the growth of the market during the forecast period
- Increasing Target Population Demanding for Bone Growth Products
- Increase in Demand for Non-invasive and Safer Surgical Treatments
- Increasing Strategic Acquisitions and New Bone Growth Product Launches
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of bone growth products and their market dynamics for the period 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.
PROMINENT VENDORS
- Bioventus
- Business Overview
- Product Offerings
- Key Strengths
- Key Strategies
- Key Opportunities
- DJO
- Johnson & Johnson
- Medtronic
- Orthofix Medical
- Stryker
- Zimmer Biomet
OTHER PROMINENT VENDORS
- BTT Health
- Business Overview
- Product Offerings
- Elizur
- Fintek Bio-Electric
- Isto Biologics
- ITO
- Kinex Medical Company
- Ossatec Benelux
- Osteotec
- Paragon 28
- Royal Biologics
- Stimulate Health
- Smith+Nephew
- SpineVision
- VQ OrthoCare
Market Segmentation by Product Type
- Bone Growth Stimulator Device
- Bone Morphogenic Protein
- Platelet Rich Plasma
Market Segmentation by Application
- Spinal Fusion Surgeries
- Oral and Maxillofacial Surgeries
- Delayed Union and Non-Union Bone Fracture
- Others
Market Segmentation by Application
- Hospitals and Clinic
- Specialty Orthopaedic and Spine Center
- Ambulatory Surgery Centers
Market Segmentation by Geography
- North America
- US
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- UK
- APAC
- China
- Japan
- India
- Australia
- South Korea
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East and Africa
- South Africa
- Saudi Arabia
- Turkey
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL BONE GROWTH PRODUCTS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 IMPACT OF SELF-POWERED IMPLANTABLE BONE GROWTH DEVICES STIMULATE FAST BONE HEALING
EXHIBIT 4 IMPACT OF USE OF BONE MORPHOGENIC PROTEINS AS ALTERNATIVE TO AUTOGRAFTS
EXHIBIT 5 DISADVANTAGES OF AUTOGENOUS BONE GRAFTS
EXHIBIT 6 IMPACT OF NEXT GENERATION MOBILE BONE GROWTH STIMULATION DEVICES
EXHIBIT 7 IMPACT OF GROWTH IN TARGET POPULATION
EXHIBIT 8 IMPACT OF INCREASE IN DEMAND FOR NON-INVASIVE & SAFER SURGICAL TREATMENTS
EXHIBIT 9 IMPACT OF RISE IN STRATEGIC ACQUISITIONS & NEW BONE GROWTH PRODUCT LAUNCHES
EXHIBIT 10 IMPACT OF STRINGENT REGULATORY APPROVAL PROCESS FOR BONE GROWTH PRODUCTS
EXHIBIT 11 IMPACT OF SIDE-EFFECTS ASSOCIATED WITH BMP-BASED ORTHOPEDIC TREATMENT
EXHIBIT 12 IMPACT OF AVAILABILITY OF MULTIPLE ALTERNATIVES
EXHIBIT 13 GLOBAL BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 14 GLOBAL BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021 & 2027 (%)
EXHIBIT 15 GLOBAL BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021 & 2027 (%)
EXHIBIT 16 GLOBAL BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021 & 2027 (%)
EXHIBIT 17 GLOBAL BONE GROWTH PRODUCTS MARKET BY END-USER 2021 & 2027 (%)
EXHIBIT 18 FIVE FORCES ANALYSIS 2021
EXHIBIT 19 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027
EXHIBIT 20 GLOBAL BONE GROWTH PRODUCTS MARKET BY PRODUCT
EXHIBIT 21 GLOBAL BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 22 GLOBAL BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE: ABSOLUTE GROWTH (%)
EXHIBIT 23 GLOBAL BONE GROWTH PRODUCTS MARKET BY BONE GROWTH STIMULATORS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 24 GLOBAL BONE GROWTH STIMULATOR DEVICES MARKET 2021–2027 ($ MILLION)
EXHIBIT 25 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 26 HISTORY OF BONE MORPHOGENETIC PROTEIN (BMP) EVOLUTION
EXHIBIT 27 BMP'S ROLE IN BONE FORMATION, GROWTH, & DIFFERENTIATION
EXHIBIT 28 GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 29 GLOBAL BONE MORPHOGENETIC PROTEINS MARKET 2021–2027 ($ MILLION)
EXHIBIT 30 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 31 GLOBAL PLATELET RICH PLASMA MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 32 GLOBAL PLATELET RICH PLASMA MARKET 2021–2027 ($ MILLION)
EXHIBIT 33 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 34 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 35 GLOBAL BONE GROWTH PRODUCTS MARKET BY APPLICATION
EXHIBIT 36 GLOBAL BONE GROWTH PRODUCTS MARKET BY APPLICATION: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 37 GLOBAL BONE GROWTH PRODUCTS MARKET BY APPLICATION: ABSOLUTE GROWTH (%)
EXHIBIT 38 GLOBAL SPINAL FUSION SURGERIES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 39 GLOBAL SPINAL FUSION SURGERIES MARKET 2021–2027 ($ MILLION)
EXHIBIT 40 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 41 GLOBAL ORAL & MAXILLOFACIAL SURGERIES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL ORAL & MAXILLOFACIAL SURGERIES MARKET 2021–2027 ($ MILLION)
EXHIBIT 43 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 44 GLOBAL DELAYED UNION & NON-UNION BONE FRACTURES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 45 GLOBAL DELAYED UNION & NON-UNION BONE FRACTURES MARKET 2021–2027 ($ MILLION)
EXHIBIT 46 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 47 PREVALENCE OF STRESS FRACTURES IN VARIOUS PLACES
EXHIBIT 48 GLOBAL BONE GROWTH PRODUCTS MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL OTHER BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 50 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 51 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 52 GLOBAL BONE GROWTH PRODUCTS MARKET BY END-USER
EXHIBIT 53 GLOBAL BONE GROWTH PRODUCTS MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 54 GLOBAL BONE GROWTH PRODUCTS MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 55 GLOBAL HOSPITALS & CLINICS BONE GROWTH PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL HOSPITALS & CLINICS BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 57 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 58 GLOBAL SPECIALTY ORTHOPEDIC & SPINE CENTER BONE GROWTH PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 59 GLOBAL SPECIALTY ORTHOPEDIC & SPINE CENTER BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 60 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 61 GLOBAL BONE GROWTH PRODUCTS MARKET BY ASCS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 62 GLOBAL ASCS BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 63 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 64 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 65 GLOBAL BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY
EXHIBIT 66 GLOBAL BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 67 GLOBAL BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 68 GLOBAL BONE GROWTH PRODUCTS MARKET: COUNTRY REVENUE 2021 (MILLIONS)
EXHIBIT 69 NORTH AMERICA BONE GROWTH PRODUCTS MARKET: KEY COUNTRIES
EXHIBIT 70 NORTH AMERICA BONE GROWTH PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 71 NORTH AMERICA BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 72 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 73 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 74 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 75 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 76 BONE GROWTH PRODUCTS MARKET IN US 2021–2027 ($ MILLION)
EXHIBIT 77 BONE GROWTH PRODUCTS MARKET IN CANADA 2021–2027 ($ MILLION)
EXHIBIT 78 BONE GROWTH PRODUCTS MARKET IN EUROPE: KEY COUNTRIES ($ MILLION)
EXHIBIT 79 EUROPE BONE GROWTH PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 80 EUROPE BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 81 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027
EXHIBIT 82 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 83 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 84 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 85 BONE GROWTH PRODUCTS MARKET IN GERMANY 2021–2027 ($ MILLION)
EXHIBIT 86 BONE GROWTH PRODUCTS MARKET IN FRANCE 2021–2027 ($ MILLION)
EXHIBIT 87 BONE GROWTH PRODUCTS MARKET IN UK 2021–2027 ($ MILLION)
EXHIBIT 88 BONE GROWTH PRODUCTS MARKET IN ITALY 2021–2027 ($ MILLION)
EXHIBIT 89 BONE GROWTH PRODUCTS MARKET IN SPAIN 2021–2027 ($ MILLION)
EXHIBIT 90 BONE GROWTH PRODUCTS MARKET IN APAC: KEY COUNTRIES
EXHIBIT 91 APAC BONE GROWTH PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 92 APAC BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 93 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027
EXHIBIT 94 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 95 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 96 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 97 BONE GROWTH PRODUCTS MARKET IN CHINA 2021–2027 ($ MILLION)
EXHIBIT 98 BONE GROWTH PRODUCTS MARKET IN JAPAN 2021–2027 ($ MILLION)
EXHIBIT 99 BONE GROWTH PRODUCTS MARKET IN INDIA 2021–2027 ($ MILLION)
EXHIBIT 100 BONE GROWTH PRODUCTS MARKET IN AUSTRALIA 2021–2027 ($ MILLION)
EXHIBIT 101 BONE GROWTH PRODUCTS MARKET IN SOUTH KOREA 2021–2027 ($ MILLION)
EXHIBIT 102 LATIN AMERICA BONE GROWTH PRODUCTS MARKET: KEY COUNTRIES
EXHIBIT 103 LATIN AMERICA BONE GROWTH PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 104 BONE GROWTH PRODUCTS MARKET IN LATIN AMERICA 2021–2027 ($ MILLION)
EXHIBIT 105 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027
EXHIBIT 106 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 107 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 108 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 109 BONE GROWTH PRODUCTS MARKET IN BRAZIL 2021–2027 ($ MILLION)
EXHIBIT 110 BONE GROWTH PRODUCTS MARKET IN MEXICO 2021–2027 ($ MILLION)
EXHIBIT 111 BONE GROWTH PRODUCTS MARKET IN ARGENTINA 2021–2027 ($ MILLION)
EXHIBIT 112 BONE GROWTH PRODUCTS IN MIDDLE EAST & AFRICA: KEY COUNTRIES
EXHIBIT 113 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 114 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 115 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027
EXHIBIT 116 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 117 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 118 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 119 BONE GROWTH PRODUCTS MARKET IN TURKEY 2021–2027 ($ MILLION)
EXHIBIT 120 BONE GROWTH PRODUCTS MARKET IN SAUDI ARABIA 2021–2027 ($ MILLION)
EXHIBIT 121 BONE GROWTH PRODUCTS MARKET IN SOUTH AFRICA 2021–2027 ($ MILLION)
EXHIBIT 122 PURE & DIVERSIFIED VENDORS IN GLOBAL BONE GROWTH PRODUCTS MARKET
EXHIBIT 123 MAJOR VENDORS IN GLOBAL BONE GROWTH PRODUCTS MARKET: STRENGTH ANALYSIS
EXHIBIT 124 KEY PLAYERS IN BONE GROWTH PRODUCTS MARKET
EXHIBIT 125 BIOVENTUS: TOTAL REVENUE 2018–2020 ($ MILLION)
EXHIBIT 126 BIOVENTUS: R&D EXPENDITURE 2018-2020 ($ MILLION)
EXHIBIT 127 JOHNSON & JOHNSON: TOTAL REVENUE 2018–2020 ($ MILLION)
EXHIBIT 128 JOHNSON & JOHNSON: R&D EXPENDITURE 2018–2020 ($ MILLION)
EXHIBIT 129 MEDTRONIC: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 130 MEDTRONIC: R&D EXPENDITURE 2019-2021 ($ MILLION)
EXHIBIT 131 MEDTRONIC: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLION)
EXHIBIT 132 MEDTRONIC: REVENUE BY GEOGRAPHY 2021 ($ MILLION)
EXHIBIT 133 ORTHOFIX: TOTAL REVENUE 2018–2020 ($ MILLION)
EXHIBIT 134 ORTHOFIX: R&D EXPENDITURE 2018–2020 ($ MILLION)
EXHIBIT 135 ORTHOFIX: REVENUE BY BUSINESS SEGMENT 2018–2020 ($ MILLION)
EXHIBIT 136 STRYKER: TOTAL REVENUE 2018–2020 ($ MILLION)
EXHIBIT 137 STRYKER: REVENUE BY BUSINESS SEGMENT 2020 ($ MILLION)
EXHIBIT 138 STRYKER: REVENUE BY GEOGRAPHY 2020 ($ MILLION)
EXHIBIT 139 ZIMMER BIOMET: TOTAL REVENUE 2018–2020 ($ MILLION)
EXHIBIT 140 ZIMMER BIOMET: REVENUE BY GEOGRAPHY 2019–2020 ($ MILLION)
EXHIBIT 141 ZIMMER BIOMET: REVENUE BY BUSINESS SEGMENT 2019–2020 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 BIOLOGICAL ACTIONS OF BMP
TABLE 4 GLOBAL NUMBER OF INCIDENT & PREVALENT CASES OF FRACTURES BY ANATOMICAL SITE IN 2019
TABLE 5 MERGERS/ACQUISITIONS IN ORTHOPEDICS & BONE BIOLOGICS MARKET
TABLE 6 SIDE EFFECTS ASSOCIATED WITH USE OF BMP
TABLE 7 FDA APPROVED ELECTRICAL BONE GROWTH STIMULATION DEVICES
TABLE 8 BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 9 BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 10 VARIOUS CARRIER MATERIAL AVAILABLE FOR BMP
TABLE 11 GLOBAL BONE MORPHOGENETIC PROTEIN MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 12 GLOBAL BONE MORPHOGENETIC PROTEIN MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 13 GLOBAL PLATELET RICH PLASMA MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 14 GLOBAL PLATELET RICH PLASMA MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 15 GLOBAL SPINAL FUSION SURGERIES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 16 GLOBAL SPINAL FUSION SURGERIES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 17 GLOBAL ORAL MAXILLOFACIAL SURGERIES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 18 GLOBAL ORAL MAXILLOFACIAL SURGERIES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 19 DELAYED UNION & NON-UNION BONE FRACTURES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 20 GLOBAL DELAYED UNION & NON-UNION BONE FRACTURES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 21 PREVALENCE OF STRESS FRACTURE & INJURY
TABLE 22 GLOBAL OTHER BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 23 GLOBAL OTHER BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 24 GLOBAL HOSPITALS & CLINICS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 25 GLOBAL HOSPITALS & CLINICS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 26 SPECIALTY ORTHOPEDIC & SPINE CENTERS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 27 SPECIALTY ORTHOPEDIC & SPINE CENTERS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 28 ASCS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 29 ASCS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 30 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 31 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 32 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 33 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)
TABLE 34 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 35 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)
TABLE 36 EUROPE BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 37 EUROPE BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 38 EUROPE BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 39 EUROPE BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)
TABLE 40 EUROPE BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 41 EUROPE BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)
TABLE 42 APAC BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 43 APAC BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 44 APAC BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 45 APAC BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)
TABLE 46 APAC BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 47 APAC BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)
TABLE 48 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 49 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 50 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 51 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)
TABLE 52 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 53 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)
TABLE 54 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 55 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 56 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 57 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)
TABLE 58 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 59 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)
TABLE 60 BIOVENTUS: MAJOR PRODUCT OFFERINGS
TABLE 61 DJO: MAJOR PRODUCT OFFERINGS
TABLE 62 JOHNSON & JOHNSON: MAJOR PRODUCT OFFERINGS
TABLE 63 MEDTRONIC: MAJOR PRODUCT OFFERINGS
TABLE 64 ORTHOFIX MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 65 STRYKER: MAJOR PRODUCT OFFERINGS
TABLE 66 ZIMMER BIOMET: MAJOR PRODUCT OFFERINGS
TABLE 67 ALTIS BIOLOGICS: MAJOR PRODUCT OFFERINGS
TABLE 68 BIO DYNAMIC TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 69 BTT HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 70 CELLUMED: MAJOR PRODUCT OFFERINGS
TABLE 71 EASTERN DME: MAJOR PRODUCT OFFERINGS
TABLE 72 ELIZUR: MAJOR PRODUCT OFFERINGS
TABLE 73 EMCYTE: MAJOR PRODUCT OFFERINGS
TABLE 74 FINTEK BIO-ELECTRIC: MAJOR PRODUCT OFFERINGS
TABLE 75 IGEA: MAJOR PRODUCT OFFERINGS
TABLE 76 ITO: MAJOR PRODUCT OFFERINGS
TABLE 77 KINEX MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 78 OSSATEC BENELUX: MAJOR PRODUCT OFFERINGS
TABLE 79 PAIN REHAB PRODUCTS: MAJOR PRODUCT OFFERINGS
TABLE 80 ROYAL BIOLOGICS: MAJOR PRODUCT OFFERINGS
TABLE 81 SHENANDOAH BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 82 SMITH+NEPHEW: MAJOR PRODUCT OFFERINGS
TABLE 83 SPECIALIZED ORTHOPEDIC SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 84 STIMULATE HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 85 TERUMO: MAJOR PRODUCT OFFERINGS
TABLE 86 GLOBAL BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 87 GLOBAL BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 88 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 89 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 90 EUROPE BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 91 EUROPE BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 92 APAC BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 93 APAC BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 94 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 95 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 96 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)
TABLE 97 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)
TABLE 98 GLOBAL BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 99 GLOBAL BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)
TABLE 100 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 101 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)
TABLE 102 EUROPE BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 103 EUROPE BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)
TABLE 104 APAC BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 105 APAC BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)
TABLE 106 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 107 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)
TABLE 108 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 109 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)
TABLE 110 GLOBAL BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 111 GLOBAL BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)
TABLE 112 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 113 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)
TABLE 114 EUROPE BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 115 EUROPE BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)
TABLE 116 APAC BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 117 APAC BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)
TABLE 118 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 119 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)
TABLE 120 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 121 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)
TABLE 122 GLOBAL BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 123 GLOBAL BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 124 BONE GROWTH STIMULATOR DEVICES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 125 BONE GROWTH STIMULATOR DEVICES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 126 BONE MORPHOGENETIC PROTEIN MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 127 BONE MORPHOGENETIC PROTEIN MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 128 PLATELET RICH PLASMA MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 129 PLATELET RICH PLASMA MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 130 SPINAL FUSION SURGERIES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 131 SPINAL FUSION SURGERIES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 132 ORAL MAXILLOFACIAL SURGERIES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 133 ORAL MAXILLOFACIAL SURGERIES IN BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 134 DELAYED UNION & NON-UNION BONE FRACTURES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 135 DELAYED UNION & NON-UNION BONE FRACTURES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 136 OTHER BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 137 OTHER BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 138 HOSPITALS & CLINICS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 139 HOSPITALS & CLINICS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 140 SPECIALTY ORTHOPEDIC & SPINE CENTER BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 141 SPECIALTY ORTHOPEDIC & SPINE CENTER BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 142 ASCS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 143 ASCS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY APPLICATION
4.3.3 MARKET SEGMENTATION BY END-USERS
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 MARKET OPPORTUNITIES & TRENDS
8.1 SELF-POWERED IMPLANTABLE BONE GROWTH DEVICES STIMULATE FAST BONE HEALING
8.2 USE OF BONE MORPHOGENIC PROTEINS AS ALTERNATIVE TO AUTOGRAFTS
8.3 NEXT GENERATION MOBILE BONE GROWTH STIMULATION DEVICES
9 MARKET GROWTH ENABLERS
9.1 GROWTH IN TARGET POPULATION
9.2 INCREASE IN DEMAND FOR NON-INVASIVE & SAFER SURGICAL TREATMENTS
9.3 RISE IN STRATEGIC ACQUISITIONS & NEW BONE GROWTH PRODUCT LAUNCHES
10 MARKET GROWTH RESTRAINTS
10.1 STRINGENT REGULATORY APPROVAL PROCESS FOR BONE GROWTH PRODUCTS
10.2 SIDE-EFFECTS ASSOCIATED WITH BMP-BASED ORTHOPEDIC TREATMENT
10.3 AVAILABILITY OF MULTIPLE ALTERNATIVES
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 GEOGRAPHY INSIGHTS
11.2.2 PRODUCT INSIGHTS
11.2.3 APPLICATION INSIGHTS
11.2.4 END-USER INSIGHTS
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 PRODUCT ANALYSIS
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 BONE GROWTH STIMULATOR DEVICES
12.3.1 MARKET OVERVIEW
12.3.2 MARKET SIZE & FORECAST
12.3.3 BONE GROWTH STIMULATION DEVICES SEGMENTATION: BY GEOGRAPHY
12.4 BONE MORPHOGENETIC PROTEIN (BMP)
12.4.1 MARKET OVERVIEW
12.4.2 MARKET SIZE & FORECAST
12.4.3 BONE MORPHOGENETIC PROTEINS SEGMENTATION: BY GEOGRAPHY
12.5 PLATELET RICH PLASMA
12.5.1 MARKET OVERVIEW
12.5.2 MARKET SIZE & FORECAST
12.5.3 PLATELET RICH PLASMA: BY GEOGRAPHY
13 APPLICATION SEGMENTATION
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 SPINAL FUSION SURGERIES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 SPINAL FUSION SURGERIES: BY GEOGRAPHY
13.4 ORAL & MAXILLOFACIAL SURGERIES
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 ORAL & MAXILLOFACIAL SURGERIES SEGMENTATION: BY GEOGRAPHY
13.5 DELAYED UNION & NON-UNION BONE FRACTURES
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 DELAYED UNION & NON-UNION BONE FRACTURES SEGMENTATION: BY GEOGRAPHY
13.6 OTHERS
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 OTHERS SEGMENTATION: BY GEOGRAPHY
14 END-USER ANALYSIS
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 HOSPITALS & CLINICS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 HOSPITALS & CLINICS SEGMENTATION: BY GEOGRAPHY
14.4 SPECIALTY ORTHOPEDIC & SPINE CENTERS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 SPECIALTY ORTHOPEDIC & SPINE CENTERS SEGMENTATION: BY GEOGRAPHY
14.5 AMBULATORY SURGICAL CENTERS (ASC)
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 ASCS SEGMENTATION: BY GEOGRAPHY
15 GEOGRAPHIC INSIGHTS
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 GEOGRAPHIC OVERVIEW
16 NORTH AMERICA
16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.2.1 NORTH AMERICA PRODUCT TYPE SEGMENTATION
16.2.2 NORTH AMERICA APPLICATION SEGMENTATION
16.2.3 NORTH AMERICA END-USER SEGMENTATION
16.3 KEY COUNTRIES
16.3.1 US: MARKET SIZE & FORECAST
16.3.2 CANADA: MARKET SIZE & FORECAST
17 EUROPE
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.2.1 EUROPE PRODUCT TYPE SEGMENTATION
17.2.2 EUROPE APPLICATION SEGMENTATION
17.2.3 EUROPE END-USER SEGMENTATION
17.3 KEY COUNTRIES
17.3.1 GERMANY: MARKET SIZE & FORECAST
17.3.2 FRANCE: MARKET SIZE & FORECAST
17.3.3 UK: MARKET SIZE & FORECAST
17.3.4 ITALY: MARKET SIZE & FORECAST
17.3.5 SPAIN: MARKET SIZE & FORECAST
18 APAC
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 APAC PRODUCT TYPE SEGMENTATION
18.2.2 APAC APPLICATION SEGMENTATION
18.2.3 APAC END-USER SEGMENTATION
18.3 KEY COUNTRIES
18.3.1 CHINA: MARKET SIZE & FORECAST
18.3.2 JAPAN: MARKET SIZE & FORECAST
18.3.3 INDIA: MARKET SIZE & FORECAST
18.3.4 AUSTRALIA: MARKET SIZE & FORECAST
18.3.5 SOUTH KOREA: MARKET SIZE & FORECAST
19 LATIN AMERICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 LATIN AMERICA PRODUCT SEGMENTATION
19.2.2 LATIN AMERICA APPLICATION SEGMENTATION
19.2.3 LATIN AMERICA END-USER SEGMENTATION
19.3 KEY COUNTRIES
19.3.1 BRAZIL: MARKET SIZE & FORECAST
19.3.2 MEXICO: MARKET SIZE & FORECAST
19.3.3 ARGENTINA: MARKET SIZE & FORECAST
20 MIDDLE EAST & AFRICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 MIDDLE EAST & AFRICA PRODUCT TYPE SEGMENTATION
20.2.2 MIDDLE EAST & AFRICA APPLICATION SEGMENTATION
20.2.3 MIDDLE EAST & AFRICA END-USER SEGMENTATION
20.3 KEY COUNTRIES
20.3.1 TURKEY: MARKET SIZE & FORECAST
20.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
20.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
21 COMPETITIVE LANDSCAPE
21.1 COMPETITION OVERVIEW
21.2 MARKET SHARE ANALYSIS
21.2.1 BIOVENTUS
21.2.2 DJO
21.2.3 JOHNSON & JOHNSON
21.2.4 MEDTRONIC
21.2.5 ORTHOFIX
21.2.6 STRYKER
21.2.7 ZIMMER BIOMET
22 KEY COMPANY PROFILES
22.1 BIOVENTUS
22.1.1 BUSINESS OVERVIEW
22.1.2 PRODUCT OFFERINGS
22.1.3 KEY STRATEGIES
22.1.4 KEY STRENGTHS
22.1.5 KEY OPPORTUNITIES
22.2 DJO
22.2.1 BUSINESS OVERVIEW
22.2.2 PRODUCT OFFERINGS
22.2.3 KEY STRATEGIES
22.2.4 KEY STRENGTHS
22.2.5 KEY OPPORTUNITIES
22.3 JOHNSON & JOHNSON
22.3.1 BUSINESS OVERVIEW
22.3.2 PRODUCT OFFERINGS
22.3.3 KEY STRATEGIES
22.3.4 KEY STRENGTHS
22.3.5 KEY OPPORTUNITIES
22.4 MEDTRONIC
22.4.1 BUSINESS OVERVIEW
22.4.2 PRODUCT OFFERINGS
22.4.3 KEY STRATEGIES
22.4.4 KEY STRENGTHS
22.4.5 KEY OPPORTUNITIES
22.5 ORTHOFIX
22.5.1 BUSINESS OVERVIEW
22.5.2 PRODUCT OFFERINGS
22.5.3 KEY STRATEGIES
22.5.4 KEY STRENGTHS
22.5.5 KEY OPPORTUNITIES
22.6 STRYKER
22.6.1 BUSINESS OVERVIEW
22.6.2 PRODUCT OFFERINGS
22.6.3 KEY STRATEGIES
22.6.4 KEY STRENGTHS
22.6.5 KEY OPPORTUNITIES
22.7 ZIMMER BIOMET
22.7.1 BUSINESS OVERVIEW
22.7.2 PRODUCT OFFERINGS
22.7.3 KEY STRATEGIES
22.7.4 KEY STRENGTHS
22.7.5 KEY OPPORTUNITIES
23 OTHER PROMINENT VENDORS
23.1 ALTIS BIOLOGICS
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.2 BIO DYNAMIC TECHNOLOGIES
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.3 BTT HEALTH
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.4 CELLUMED
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.5 EASTERN DME
23.5.1 BUSINESS OVERVIEW
23.5.2 PRODUCT OFFERINGS
23.6 ELIZUR
23.6.1 BUSINESS OVERVIEW
23.6.2 PRODUCT OFFERINGS
23.7 EMCYTE
23.7.1 BUSINESS OVERVIEW
23.7.2 PRODUCT OFFERINGS
23.8 FINTEK BIO-ELECTRIC
23.8.1 BUSINESS OVERVIEW
23.8.2 PRODUCT OFFERINGS
23.9 IGEA
23.9.1 BUSINESS OVERVIEW
23.9.2 PRODUCT OFFERINGS
23.10 ITO
23.10.1 BUSINESS OVERVIEW
23.10.2 PRODUCT OFFERINGS
23.11 KINEX MEDICAL
23.11.1 BUSINESS OVERVIEW
23.11.2 PRODUCT OFFERINGS
23.12 OSSATEC BENELUX
23.12.1 BUSINESS OVERVIEW
23.12.2 PRODUCT OFFERINGS
23.13 PAIN REHAB PRODUCTS
23.13.1 BUSINESS OVERVIEW
23.13.2 PRODUCT OFFERINGS
23.14 ROYAL BIOLOGICS
23.14.1 BUSINESS OVERVIEW
23.14.2 PRODUCT OFFERINGS
23.15 SHENANDOAH BIOTECHNOLOGY
23.15.1 BUSINESS OVERVIEW
23.15.2 PRODUCT OFFERINGS
23.16 SMITH+NEPHEW
23.16.1 BUSINESS OVERVIEW
23.16.2 PRODUCT OFFERINGS
23.17 SPECIALIZED ORTHOPEDIC SOLUTIONS
23.17.1 BUSINESS OVERVIEW
23.17.2 PRODUCT OFFERINGS
23.18 STIMULATE HEALTH
23.18.1 BUSINESS OVERVIEW
23.18.2 PRODUCT OFFERINGS
23.19 TERUMO
23.19.1 BUSINESS OVERVIEW
23.19.2 PRODUCT OFFERINGS
24 REPORT SUMMARY
24.1 KEY TAKEAWAYS
24.2 STRATEGIC RECOMMENDATIONS
25 QUANTITATIVE SUMMARY
25.1 MARKET BY PRODUCT TYPE
25.1.1 NORTH AMERICA: PRODUCT TYPE SEGMENTATION
25.1.2 EUROPE: PRODUCT TYPE SEGMENTATION
25.1.3 APAC: PRODUCT TYPE SEGMENTATION
25.1.4 LATIN AMERICA: PRODUCT TYPE SEGMENTATION
25.1.5 MIDDLE EAST & AFRICA: PRODUCT TYPE SEGMENTATION
25.2 MARKET BY APPLICATION
25.2.1 NORTH AMERICA: APPLICATION SEGMENTATION
25.2.2 EUROPE: APPLICATION SEGMENTATION
25.2.3 APAC: APPLICATION SEGMENTATION
25.2.4 LATIN AMERICA: APPLICATION SEGMENTATION
25.2.5 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION
25.3 MARKET BY END-USER
25.3.1 NORTH AMERICA: END-USER SEGMENTATION
25.3.2 EUROPE: END-USER SEGMENTATION
25.3.3 APAC: END-USER SEGMENTATION
25.3.4 LATIN AMERICA: END-USER SEGMENTATION
25.3.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
25.4 MARKET BY GEOGRAPHY
25.4.1 BONE GROWTH STIMULATOR DEVICES SEGMENTATION: BY GEOGRAPHY
25.4.2 BONE MORPHOGENETIC PROTEIN SEGMENTATION: BY GEOGRAPHY
25.4.3 PLATELET RICH PLASMA SEGMENTATION: BY GEOGRAPHY
25.4.4 SPINAL FUSION SURGERIES SEGMENTATION: BY GEOGRAPHY
25.4.5 ORAL & MAXILLOFACIAL SURGERIES SEGMENTATION: BY GEOGRAPHY
25.4.6 DELAYED UNION & NON-UNION BONE FRACTURES: BY GEOGRAPHY
25.4.7 OTHERS SEGMENTATION: BY GEOGRAPHY
25.4.8 HOSPITALS & CLINICS SEGMENTATION: BY GEOGRAPHY
25.4.9 SPECIALTY ORTHOPEDIC & SPINE CENTER SEGMENTATION: BY GEOGRAPHY
25.4.10 ASCS SEGMENTATION: BY GEOGRAPHY
26 APPENDIX
26.1 ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
What is the size of the bone growth products and the growth rate during the forecast period?
Which region has the highest growth rate in the bone growth products market?
Who are the key players in the bone growth products industry?
What are the factors driving the demand for the bone growth products market?
What are the trends in the bone growth products market?